Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
Lung Cancer remains a major cause of death in of both women and men in our society. Lung cancer treatment paradigms have changed enormously as we’ve started to understand the genetic complexity and the multiple driver mutations influencing the disease. Therapeutics directed towards, or to inhibit si...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2018 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (95 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in new era of personalised medicine / / edited by Vera Hirsh and Barbara Melosky.
by: Barbara Melosky
Published: (2015) -
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
by: Uchino, Junji
Published: (2021) -
Small Cell Lung Cancer: A New Era Is Beginning?
by: Morabito, Alessandro
Published: (2021) -
Toxicity and Pharmacokinetic Biomarkers for Personalized Non-Small Cell Lung Cancer Treatment.
by: Svedberg, Anna.
Published: (2020.) -
Personalised cancer medicine / / Anne Kerr, Choon Key Chekar, and others.
by: Kerr, Anne,
Published: (2021.)